Information content as a health system screening tool for rare diseases. [PDF]
Groza T +11 more
europepmc +1 more source
Covid-19 outbreak and beyond: a retrospect on the information content of short-time workers for GDP now- and forecasting. [PDF]
Kaufmann S.
europepmc +1 more source
E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov +3 more
wiley +1 more source
Information Content and Maximum Entropy of Compartmental Systems in Equilibrium. [PDF]
Metzler H, Sierra CA.
europepmc +1 more source
In Silico Tools to Extract the Drug Design Information Content of Degradation Data: The Case of PROTACs Targeting the Androgen Receptor. [PDF]
Apprato G +4 more
europepmc +1 more source
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau +8 more
wiley +1 more source
Deep learning-based high-information-content graph representation of early stage bacterial biofilms. [PDF]
Nersesyan LE +5 more
europepmc +1 more source
A smartphone-based self-care application for patients with urinary tract stones: identification of information content and functional capabilities. [PDF]
Shahmoradi L +6 more
europepmc +1 more source
KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan +16 more
wiley +1 more source

